You just clicked a link to go to another website. If you continue, you will leave this site and go to a site run by someone else.
Medtronic does not review or control the content on the other website, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in the United Kingdom.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations, except those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Click “OK” to confirm you are a Healthcare Professional.
Obsessive-Compulsive Disorder (OCD)
The Reclaim DBS system consists of the following implanted components:
Sometimes called a “brain pacemaker,” the neurostimulator produces the electrical pulses needed for stimulation. These electrical pulses are delivered through the extension and lead to the targeted areas in the brain. The pulses can be adjusted wirelessly to check or change the neurostimulator settings.
Indications: The Medtronic Reclaim DBS Therapy is indicated for bilateral stimulation of the anterior limb of the internal capsule, AIC, as an adjunct to medications and as an alternative to anterior capsulotomy for treatment of chronic, severe, treatment-resistant obsessive compulsive disorder (OCD) inadult patients who have failed at least three selective serotonin reuptake inhibitors (SSRIs).
Neurologists and Neurosurgeons have used electrical stimulation since the 1960s as a way to locate and distinguish specific sites in the brain. Medtronic developed brain stimulation technology in the 1980s in conjunction with leading international physician researchers.
Medtronic DBS Therapy is currently approved to manage symptoms of advanced Parkinson's disease, essential tremor, dystonia, and obsessive-compulsive disorder. Since 1997, more than 135,000 people worldwide have received Medtronic DBS Therapy.1
There is no cure for OCD at this time. Reclaim DBS Therapy may treat some of the symptoms of OCD, but does not cure the underlying condition. If stimulation is discontinued, symptoms will likely return.
Medtronic, Inc. data on file.
Indications: The Medtronic Reclaim™ DBS Therapy is indicated for bilateral stimulation of the anterior limb of the internal capsule, AIC, as an adjunct to medications and as an alternative to anterior capsulotomy for treatment of chronic, severe, treatment-resistant obsessive compulsive disorder (OCD) inadult patients who have failed at least three selective serotonin reuptake inhibitors (SSRIs).
Reclaim DBS Therapy for OCD is available in a very limited number of centres. Only a specialised multidisciplinary group of physicians can determine whether this therapy is right for the patient.
Information on this site should not be used as a substitute for talking with your doctor. Always talk with your doctor about diagnosis and treatment information.